Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma

Cancer

Volumn 100, Issue 2, 2004, Pages 366-375

  Li, Chi Cheng ^a   Tien, Hwei Fang ^b   Tang, Jih Luh ^b   Yao, Ming ^b   Chen, Yao Chang ^b   Su, Ih Jen ^b   Hsu, Su Ming ^b   Hong, Ruey Long ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Epstein Barr virus; Natural killer cell; Sinonasal; T cell receptor gene

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0346724526     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11908     Document Type: Article

References (37)

1. Jaffe ES. Classification of natural killer (NK) cell and NK-like T cell malignancies. Blood. 1996;87:1207-1210.
2. Chan JKC, Yip TTC, Tsang WYW, et al. Detection of Epstein-Barr virus RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol. 1994;18:938-946.
3. Van Gorp J, Liu WP, Jacobse K, et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol. 1994;173:81-87.
4. Kwong YL, Chan ACL, Liang RHS. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol. 1997;15:71-79.
5. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinico-pathological features of malignant lymphoma in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer. 1984;34:143-148.
6. Ng CS, Chan JKC, Lo STH, Poon YF. Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese. A study of 75 cases in Hong Kong. Pathology. 1986;18:419-425.
7. Misad O, Solidoro A, Quiroz L, Olivares L. An overview of lymphoreticular malignancies in Peru. Progr Cancer Res Ther. 1984;27:85-97.
8. Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol. 1996;20:103-111.
9. Stewart JP. Progressive lethal granulomatous ulceration of the nose. J Laryngol Otol. 1933;48:657-701.
10. Eichel BS, Harrison EG, Devine KD, Scanlon PW, Brown HA. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg. 1966;112:597-605.
11. Kassel SH, Echevarria RA, Guzzo FP. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer. 1969;23:920-935.
12. Lien HC, Lin CW, Huang PH, Chang ML, Hsu SM. Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: comparison with CD56-negative peripheral T-cell lymphomas. Lab Invest. 2000;80:893-900.
13. Ho FCS, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 1990;21:1041-1050.
14. Jaffe ES. Nasal and nasal-type NK/T-cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology. 1995;27:581-583.
15. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood. 1994;83:2255-2260.
16. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today. 1992;13:392-395.
17. Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells. Blood. 1995;85:2654-2670.
18. Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54-63.
19. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998;83:449-456.
20. Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16:70-77.
21. Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer. 1995;75:1281-1291.
22. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13:666-670.
23. Cheung MMC, Chan JKC, Lau WH, Ngan RKC, Foo WWL. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002;54:182-190.
24. Shipp M, Harrington D, Anderson J, et al. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-994.
25. Hoogstraten B. Reporting treatment results in solid tumors. In: Byse ME, Staquet MJ, Sylvester RJ, editors. Cancer clinical trials, method and practice. Oxford: Oxford University, 1984:139-152.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
27. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphomas Study Group. Blood. 1994;84:1361-1392.
28. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November, 1997. J Clin Oncol. 1999;17:3835-3849.
29. Ansell SM, Habermann TM, Kurtin PJ, et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997;15:2296-2301.
30. Logsdon MD, Ha CS, Kavadi VS, Cabanillas F, Hess MA, Cox JD. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997;80:477-488.
31. Aviles A, Rodriguez L, Guzman R, Talavera A, Garcia EL, Diaz-Maqueo JC. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol. 1992;10:141-147.
32. Itami J, Itami M, Mikata A, et al. Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of the radiation therapy. Int J Radiat Oncol Biol Phys. 1991;20:797-802.
33. Ribrag V, Ell Hajj M, Janot F, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 2001;15:1123-1126.
34. Sobrevilla-Calvo P, Meneses A, Alfaro P, Bares JP, Amador J, Reynoso EE. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol. 1993;32:69-72.
35. Kim WS, Song SY, Ahn YC, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol. 2001;12:349-352.
36. Nawa Y, Takenaka K, Shinagawa K, et al. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;12:1321-1322.
37. Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant. 1997;19:91-93.